I remember the PANC board reading exactly like this. I said it was a scam and everyone was so impressed that a DOCTOR was on the board and a CEO. It had a negative EPS too and it was trumped up by none other than the experts. I have not read one thing by you so called experts that can back up any reason to own this stock and how they are going to get out of the red. So sell me on this and get me to buy if this is such a bargain.
You come here acting like a total idiot, professing to make money as a day trader, call all biotechs scams, compare SGEN to DNDN and now have an ax to grind with the CEO compensation. You contribute nothing useful to this board so I also will put you on ignore....
Stop paying $6,286,460. for total compensation a year to the so called VIPS unless the company is making a profit. It's all there in black and white with an article by Forbes and the financial data was provided by Morningstar. Just type in Dr. Clay B. Siegall and it shows in 2013 he was given restricted stock awards of $2,257,200 plus option awards of $2,644,713. and that the total compensation was $6,286,460. When the company starts showing a profit, award them accordingly but not until. That would be a start. Okay, everyone hammer me again. I'm just stating the facts after I did my research on SGEN but I am sure all of you who own already know this.
See his affiliation and stock ownership of ALDR and RARE both sporting negative eps. He has been a board member in Ultragenyx Pharma too. Mirna Therapeutics - you name it. Lots of irons in the FIRE. By the way, RARE is down $24.00 a share. You can run as many of these as you want as long as you have pumpers to sell you the shares.
Gee, why not buy yourself some ISIS. Let me guess, another cancer research. Down $26.00 a share from the 52 week high. Negative EPS and the CEO makes 1.55 million. Where do you think these guys are getting that kind of money to pay themselves first, before there are any profits in the company? Hmmmm-they should make a movie called Wolves of Wall Street. Maybe that would get the message across.
This guy is just a garden variety troll, and not a very smart one, and very possibly just another one of Ricky's aliases. He's cherry picking examples that have nothing to do with SGEN and its assets, technology and pipeline. You're better off simply ignoring him, which is my plan going forward.
WHAT? Punch up Competitors to the left hand side of your screen. See where the EBITDA reads -53.12m? See the net income of -62.56 million See the PEG 5 yr. expected of -10.66? These are all supposed to be positive numbers. Where do you see a large cash position. Look at the comp of PFE just to the right of the screen. Wouldn't that be a better bet? THEY ARE MAKING MONEY not bleeding plus Pfizer pays a dividend.
Oh wait-Here's another one. PCYC -Biotech-Cancer research-Down $66.00 a share (52 weeks) These biotechs are like reading the same book over and over.
DNDN -Biotech-Seattle-Founded in 1992 - CEO makes 1.26 mill with no profits in sight. Cancer Research- Pull up a 5 year chart and check out the action.
SGEN-Biotech-Bothell-Founded 5 years later in 1997 - Co-Founder makes 1.38 Mill with no profits in sight. Cancer Research- Just wait 5 years and the chart will look just like DNDN
Notice that SGEN is still essentially a developmental biotech, so a negative EPS is not unexpected. Notice also that your comparison to DNDN could not be more irrelevant, and just goes to show that you're pathetic.
Notice that this thing has a negative EPS. Do you know what that means? That they are not making ANY money but bleeding. Compare to DNDN the once high flyer. They too have a negative EPS and look where they are today. DNDN was way up there even though they were out of cash. SGEN needs some new wonder drug or they will be in the same sinking boat.
It's down $15.00 a share this year well off its high. I say daytrade this thing and make some money. The financial attention I have given any stock has made me some money and I am never going to be a bagholder of a scam. Ever hear of buy low and sell just a bit higher for a quick profit and not dream that this BIO is the next big thing? What are you betting on; that Cramer will pump this thing up to its all time high.
I own a small position and would like to add to it but not sure there is anything in the near term to potentially drive the share price higher? Is there anything I am missing that is due to come out on this near term that might be a catalyst? Other than possible takeover target, I can't find any reason to buy more shares at this price, am I missing anything?